Gene Query: MRPL58

Dataset Description Geneva Score
Control of prostate tumour growth by the long non-coding RNA GHSROS 35.32
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 25.12
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.15
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.5
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.06
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 8.77
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 8.75
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 8.52
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 8.52
Oncogenic roles of ARID5B in T-ALL 8.52
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.86
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.75
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.67
Transcriptomic analyssis following EHMT1/2 inhibition 7.09
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.82
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 6.82
Genome wide expression change by RNF168 knocking down in NEC cells 6.8
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.8
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.79
ETV7 and interferon response 6.79
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 6.79
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.78
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 6.72
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 6.69
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 6.69
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.64
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 6.49
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 6.45
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 6.41
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 6.37
Global analysis of enhancer targets: Mosaic-seq 6.28
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 6.25
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 6.25
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.25
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 6.21
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.11
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.01
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.96
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.92
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 5.89
MYCi975 regulates MYC target genes 5.8
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.75
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.69
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 5.6
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.5
The cohesin complex prevents Myc-induced replication stress 5.4
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 5.37
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.3
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.03
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.86
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 4.84
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.74
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 4.74
Human Treg IL-12 stimulation 4.69
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.68
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.68
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.63
DART-seq: an antibody-free method for global m6A detection 4.62
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.61
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.56
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.51
scRNASeq analysis of cycling cardiomyocytes 4.5
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.49
A549 cells and MSR-A549 cells 4.47
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 4.47
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 4.43
Impact of dieldrin on transcription in Jurkat T cells 4.42
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.42
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.38
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.35
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.31
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 4.24
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.21
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 4.18
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 4.18
CD73 knockdown effect in pancreatic cancer cell lines 4.15
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 4.11
Differential gene expression of human melanoma cells [RNA-seq] 4.11
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 4.11
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 4.07
Lysine benzoylation is a novel histone mark 4.07
Lysine benzoylation is a novel histone mark [RNA-seq] 4.07
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 4.04
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 4.04
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.03
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 4.03
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.0
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 3.99
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.99
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 3.99
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.96
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 3.94
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 3.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 3.91
Regulation of protein translation during mitosis 3.86
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 3.82
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 3.82
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.81
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 3.77
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.74
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.73
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 3.73
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.72
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.66
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.65
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 3.62
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 3.61
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.58
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.58
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 3.57
N6-methyladenine DNA Modification in Glioblastoma 3.57
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.57
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.53
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.52
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 3.48
RNAseq of HEK293 cells after Chtop knockdown 3.47
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.47
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.46
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.46
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.44
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.4
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.39
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 3.35
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 3.35
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 3.34
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 3.31
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 3.31
Identification of HOXB13 target genes responsive to BET inhibitors 3.29
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.27
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.27
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.26
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 3.25
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 3.22
The landscape of alternative splicing in aggressive prostate cancers 3.2
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 3.2
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 3.2
The comparison of high-throughput single-cell RNA-seq methods 3.19
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 3.19
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.17
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.17
Oncogenic MYC induces a dependency on the spliceosome in human cancer 3.15
m6A-dependent regulation of messenger RNA stability 3.14
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 3.13
CROP-Seq in Primary Human T Cells 3.11
Effect of Influenza virus infection on lncRNA expression in A549 cells 3.1
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.09
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 3.09
TGF-β promotes genomic instability after loss of RUNX3 3.08
RNA-seq analysis of control and Myc-induced U2OS cells 3.08
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 3.06
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 3.06
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 3.04
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.03
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.03
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 3.02
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.01
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.01
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.01
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.0
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 2.98
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.97
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.93
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.92
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.92
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.92
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 2.91
Hypoxic transcriptome of SQ20B human head and neck cancer cells 2.9
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.88
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.88
Trans-differentiation of human adult peripheral blood T cells into neurons 2.87
SF3B1 Degron knockdown RNA-seq 2.86
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.85
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.83
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.82
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 2.81
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.8
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.8
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 2.8
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.79
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.79
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.77
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.77
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.76
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 2.76
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.75
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.75
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.74
RNA-seq analyisis of PUM2 knockout cells 2.74
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.73
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 2.72
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.72
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 2.72
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 2.72
Effect of from Human Umbilical Vein Endothelial Cells 2.71
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.7
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.7
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.7
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 2.7
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 2.7
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 2.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 2.69
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 2.68
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.65
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.65
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.64
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 2.63
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 2.63
RNA-seq analyses of human prostate cancer cells 2.63
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 2.62
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 2.61
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.6
Cell responses to dysregulated VZV-induced cell-cell fusion 2.59
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.56
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.55
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.55
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 2.55
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.53
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.53
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.53
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.52
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.52
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.51
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.51
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.51
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.5
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.5
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.49
T47D RNA-seq and ChrRNA-seq data 2.49
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 2.49
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 2.48
Ribosome profiling upon inhibition of eIF4A 2.47
Illumina Total RNA-seq in HeLa 2.45
Identification of transcription start sites for human A549 cell line using ReCappable-seq 2.45
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 2.44
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.4
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 2.38
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.36
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.35
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.3
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.29
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.29
Regulatory network controlling tumor-promoting inflammation in human cancers 2.29
Functional significance of the HIV-1 Tat signature amino acid residues 2.26
MCF-7 as a model for functional analysis of breast cancer risk variants 2.26
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.26
KLF6-dependent transcription in renal cancer cells 2.22
FBXW7 modulates stress response by post-translational modification of HSF1 2.21
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.21
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 2.18
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 2.14
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.12
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.11
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.11
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.1
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.09
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.06
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 2.05
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.05
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.04
Transcriptome analysis of SKI knock-out in HL60 cells 2.03
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.03
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 2.0
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.98
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.98
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.97
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.97
A single cell reference map for human blood and tissue T cell activation 1.96
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.95
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 1.92
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 1.92
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.9
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.9
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.9
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.9
RNA-seq of IL-4 stimulated human keratinocytes 1.89
Functional role of SLIT2 and ROBO1 in trophoblasts 1.89
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.89
Seletive inhibition of CDK9 in DLBCL cell lines 1.86
Overexpression and knockdown experiment for circCSNK1G3 1.85
Human Treg NaCl stimulation 1.85
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 1.85
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.84
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.8
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.79
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 1.78
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 1.78
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 1.78
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 1.78
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 1.76
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.76
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 1.76
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 1.76
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 1.74
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 1.74
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.72
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.72
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.71
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.71
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.71
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.71
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.71
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 1.69
Genome wide miR-191 target profile determined by RIP and gene expression profiling 1.69
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 1.69
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 1.69
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.69
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 1.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.68
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.67
Iron response of HepG2 cells 1.65
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 1.65
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 1.65
Cajal bodies are linked to genome conformation [RNA-Seq] 1.64
Cajal bodies are linked to genome conformation 1.64
Effect of CHKA knockdown on C4-2 cell transcriptome 1.64
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 1.64
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.63
mRNA recovered upon RNF219 IP. [RNA-IP] 1.62
Transcriptional profile in human S. haematobium infection 1.6
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.58
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.58
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 1.57
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.55
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.54
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.53
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.53
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.51
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.51
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 1.5
RNA-seq analysis upon ARID1B overexpression 1.49
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 1.48
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 1.48
PRDM1 inhibits proliferation of human colon cancer organoids 1.46
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 1.45
RNA editing in nascent RNA affects pre-mRNA splicing 1.45
Transcriptome sequencing of K-562 cells 1.44
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 1.43
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 1.42
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 1.42
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.41
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.4
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.4
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.39
NR2F2 study 1.39
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.37
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.34
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.32
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.32
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.31
Chromatin landscape of human visceral and subcutaneous adipocytes 1.3
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.3
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.29
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 1.29
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 1.29
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.28
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 1.23
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 1.23
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.22
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.19
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 1.18
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.17
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 1.17
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.15
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.11
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.04
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.03
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.03
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 1.03
SNHG5 siRNA knock down in HCT116 cells 1.02
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.01
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.0
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.99
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.98
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.98
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.98
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.96
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.95
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.95
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.94
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.94
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.93
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.93
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.93
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.9
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.89
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.89
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.89
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.87
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.87
Transcriptomic analysis of human tonsillar TFH subsets 0.87
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.87
Effect of ILF3 on translation during homeostasis and the antiviral response 0.84
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.82
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.82
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.81
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 0.79
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.77
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.75
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.75
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.73
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.72
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 0.71
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.71
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.7
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.69
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.68
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.68
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.68
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.66
Effect of PBK knockdown on C4-2 cell transcriptome 0.66
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.65
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.65
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.63
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.62
Impact on erythroid progenitor type on erythroid differntiation 0.61
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.6
RNAseq of cell lines with knocked in ESR1 mutations 0.59
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.57
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.57
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.57
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.57
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.57
TT-Seq captures the human transient transcriptome 0.57
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.56
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.56
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 0.56
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.54
Epigenetic reprogramming of melanoma cells by vitamin C treatment 0.54
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.54
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.53
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.53
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.52
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.52
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 0.52
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.51
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.5
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.5
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.49
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.49
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.48
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.47
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.47
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.47
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.45
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.45
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.45
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.45
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.44
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.42
Transcriptome-wide response to synthetic chromatin protein PcTF 0.42
Gene expression changes due to PARP knockdown in human cells 0.42
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.42
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.42
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.4
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.4
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.39
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.39
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.39
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.37
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.37
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.36
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.35
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.32
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.3
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.28
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.27
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.26
HEK293 TFAM Knockout Expression Study 0.26
Human Treg IFNg/IL-10 subpopulations 0.24
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.24
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.23
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.21
RNA seq with AML (NB4) cells upon FTO inhibition 0.21
RNA seq analysis of human Fetal and adult derived Enterospheres 0.2
Exploring ILF2 regulatory genes by next-generation sequencing 0.2
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.19
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.19
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.18
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.16
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.16
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.15
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.13
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 0.11
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.11
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.11
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.1
RNA-seq data 0.08
Genome-wide analysis of the Integrator complex 0.08
Genome-wide analysis of the Integrator complex (HTS) 0.08
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.06
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.05
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.05
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.04
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.04
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.0
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.0
O-glcnAc reprograms cellular energetics 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation